Entera Bio Ltd. (ENTX)

Enfusion Statistics

Total Valuation

Entera Bio has a market cap or net worth of $85.45 million. The enterprise value is $72.07 million.

Market Cap	85.45M
Enterprise Value	72.07M

Important Dates

The last earnings date was Friday, August 8, 2025, after market close.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Entera Bio has 45.45 million shares outstanding. The number of shares has increased by 26.34% in one year.

Current Share Class	45.45M
Shares Outstanding	45.45M
Shares Change (YoY)	+26.34%
Shares Change (QoQ)	+7.97%
Owned by Insiders (%)	1.98%
Owned by Institutions (%)	8.48%
Float	28.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	498.33
Forward PS	n/a
PB Ratio	4.79
P/TBV Ratio	4.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	434.14
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.47, with a Debt / Equity ratio of 0.01.

Current Ratio	10.47
Quick Ratio	5.89
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -82.22% and return on invested capital (ROIC) is -50.28%.

Return on Equity (ROE)	-82.22%
Return on Assets (ROA)	-44.56%
Return on Invested Capital (ROIC)	-50.28%
Return on Capital Employed (ROCE)	-59.41%
Revenue Per Employee	$8,300
Profits Per Employee	-$530,100
Employee Count	20
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, Entera Bio has paid $14,000 in taxes.

Income Tax	14,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.33% in the last 52 weeks. The beta is 1.52, so Entera Bio's price volatility has been higher than the market average.

Beta (5Y)	1.52
52-Week Price Change	+8.33%
50-Day Moving Average	1.96
200-Day Moving Average	2.01
Relative Strength Index (RSI)	42.53
Average Volume (20 Days)	291,658

Short Selling Information

Short Interest	37,398
Short Previous Month	55,283
Short % of Shares Out	0.08%
Short % of Float	0.13%
Short Ratio (days to cover)	1.04

Income Statement

In the last 12 months, Entera Bio had revenue of $166,000 and -$10.60 million in losses. Loss per share was -$0.25.

Revenue	166,000
Gross Profit	n/a
Operating Income	-10.59M
Pretax Income	-8.51M
Net Income	-10.60M
EBITDA	-10.55M
EBIT	-10.59M
Loss Per Share	-$0.25

Balance Sheet

The company has $10.86 million in cash and $203,000 in debt, giving a net cash position of $10.66 million or $0.23 per share.

Cash & Cash Equivalents	10.86M
Total Debt	203,000
Net Cash	10.66M
Net Cash Per Share	$0.23
Equity (Book Value)	17.26M
Book Value Per Share	0.38
Working Capital	17.47M

Cash Flow

In the last 12 months, operating cash flow was -$6.66 million and capital expenditures -$40,000, giving a free cash flow of -$6.70 million.

Operating Cash Flow	-6.66M
Capital Expenditures	-40,000
Free Cash Flow	-6.70M
FCF Per Share	-$0.15

Margins

Gross Margin	n/a
Operating Margin	-6,378.92%
Pretax Margin	-6,378.31%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Entera Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-26.34%
Shareholder Yield	-26.34%
Earnings Yield	-12.82%
FCF Yield	-8.09%

Analyst Forecast

The average price target for Entera Bio is $10.00, which is 431.92% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	431.92%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3